L&C BIO Co.,LTD (KOSDAQ:290650)
77,500
-5,700 (-6.85%)
Jun 9, 2026, 3:30 PM KST
188.10% (1Y)
| Market Cap | 2.09T +288.7% |
| Revenue (ttm) | 98.10B +34.1% |
| Net Income | -135.14B |
| EPS | -5,630.74 |
| Shares Out | 26.97M |
| PE Ratio | n/a |
| Forward PE | 65.29 |
| Dividend | 50.00 (0.06%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 450,397 |
| Open | 84,500 |
| Previous Close | 83,200 |
| Day's Range | 76,100 - 86,100 |
| 52-Week Range | 25,500 - 125,000 |
| Beta | 1.38 |
| Analysts | Buy |
| Price Target | 95,000.00 (+22.58%) |
| Earnings Date | Aug 14, 2026 |